Australia has a successful adolescent immunization program, routinely achieving high vaccine coverage for teenagers.

The Royal Australian College of GPs (RACGP) has called on the Western Australian Government to listen to the calls of families across the state and ...

GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

The global vaccine market accounted for $32,463 million in 2019 and is expected to reach $54,168 million by 2027, registering a CAGR of 6.6% from 2020 to 2027. It is estimated that vaccine market is ...

Though GSK is definitely not the best large-cap drugmaker to have in one's portfolio, we believe there is potential for its ...

There is also the MenACWY vaccine for teenagers in Year 9 and Year 10, or aged 13 to 14. Dr Shamez Ladhani, a consultant ...

Australia has a successful adolescent immunisation program, routinely achieving high vaccine coverage for teenagers.Authors Archana Koirala ...

London: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of ...

“In South Australia, under national and state funded programs, the meningococcal B vaccine is available and free for infants ...

Health authorities in South Australia have issued the alert after the 14-year-old girl from Adelaide was hospitalised with invasive meningococcal disease, identified as serogroup B strain.

European Commission approves GSK’s fully liquid Menveo meningococcal vaccine: London, UK Friday, November 29, 2024, 11:00 Hrs [IST] GSK plc announced that the European Commissio ...